Get started
Quest Diagnostics IncorporatedQuest Diagnostics IncorporatedQuest Diagnostics Incorporated

Quest Diagnostics Incorporated

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

DGX chart

Key stats

Market capitalization
‪14.06 B‬USD
Dividend yield (indicated)
2.35%
Price to earnings Ratio (TTM)
17.02
Basic EPS (TTM)
7.59USD
Net income
‪850.00 M‬USD
Revenue
‪9.25 B‬USD
Shares float
‪109.71 M‬
Beta (1Y)
0.19

About Quest Diagnostics Incorporated

Sector
Health Services
Industry
Services to the Health Industry
CEO
James E. Davis
Website
questdiagnostics.com
Headquarters
Secaucus
Employees (FY)
‪48 K‬
Founded
1967
ISIN
US74834L1008
FIGI
BBG000BN84F3
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DGX is 126.98 USD — it has decreased by 0.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Quest Diagnostics Incorporated stocks are traded under the ticker DGX.
Quest Diagnostics Incorporated is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
DGX stock is 0.99% volatile and has beta coefficient of 0.19. Check out the list of the most volatile stocks — is Quest Diagnostics Incorporated there?
One year price forecast for Quest Diagnostics Incorporated has a max estimate of 155.00 USD and a min estimate of 125.00 USD.
DGX earnings for the last quarter are 2.22 USD whereas the estimation was 2.19 USD which accounts for 1.45% surprise. Estimated earnings for the next quarter are 2.11 USD. See more details about Quest Diagnostics Incorporated earnings.
Quest Diagnostics Incorporated revenue for the last quarter amounts to ‪2.30 B‬ USD despite the estimated figure of ‪2.27 B‬ USD. In the next quarter revenue is expected to reach ‪2.25 B‬ USD.
Yes, you can track Quest Diagnostics Incorporated financials in yearly and quarterly reports right on TradingView.
DGX stock has fallen by 4.29% compared to the previous week, the month change is a 0.59% fall, over the last year Quest Diagnostics Incorporated has showed a 11.46% decrease.
DGX net income for the last quarter is ‪192.00 M‬ USD, while the quarter before that showed ‪223.00 M‬ USD of net income which accounts for −13.90% change. Track more Quest Diagnostics Incorporated financial stats to get the full picture.
Today Quest Diagnostics Incorporated has the market capitalization of ‪14.06 B‬, it has decreased by 1.70% over the last week.
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.75 USD. As of today, Dividend Yield (TTM)% is 2.24%. Tracking Quest Diagnostics Incorporated dividends might help you take more informed decisions.
Quest Diagnostics Incorporated dividend yield was 2.06% in 2023, and payout ratio reached 37.76%. The year before the numbers were 1.69% and 33.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, DGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quest Diagnostics Incorporated stock right from TradingView charts — choose your broker and connect to your account.
DGX reached its all-time high on Dec 31, 2021 with the price of 174.16 USD, and its all-time low was 3.31 USD and was reached on Dec 18, 1996.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪48.00 K‬ employees. See our rating of the largest employees — is Quest Diagnostics Incorporated on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Quest Diagnostics Incorporated technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Quest Diagnostics Incorporated stock shows the sell signal. See more of Quest Diagnostics Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Quest Diagnostics Incorporated future price: according to them, DGX price has a max estimate of 155.00 USD and a min estimate of 125.00 USD. Read a more detailed Quest Diagnostics Incorporated forecast: see what analysts think of Quest Diagnostics Incorporated and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Quest Diagnostics Incorporated EBITDA is ‪1.81 B‬ USD, and current EBITDA margin is 19.35%. See more stats in Quest Diagnostics Incorporated financial statements.